FDG PET/CT in a Case of Thoracic SMARCA4-Deficient Undifferentiated Tumor-Reference-Cited by-同舟云学术

FDG PET/CT in a Case of Thoracic SMARCA4-Deficient Undifferentiated Tumor

Published:2023-10-23 Issue:12 Volume:48 Page:1111-1113
ISSN:1536-0229
Container-title:Clinical Nuclear Medicine
language:en
Short-container-title:Clin Nucl Med

Author:

Guo Jia¹,Liao Zhongjian²,Chen Qing³,Dong Aisheng⁴,Huang Mouqing¹

Affiliation:

1. Departments of Nuclear Medicine

2. Radiology

3. Pathology, The People's Hospital of Ganzhou, Ganzhou, Jiangxi Province

4. Department of Nuclear Medicine, The First Affiliated Hospital of Naval Medical University, Shanghai, China.

Abstract

Abstract Thoracic SMARCA4-deficient undifferentiated tumor is a rare, newly recognized poorly differentiated tumor with poor prognosis. FDG PET/CT findings of thoracic SMARCA4-deficient undifferentiated tumor are rarely reported. We describe FDG PET/CT findings in a case of thoracic SMARCA4-deficient undifferentiated tumor. The tumor presented as a pleural mass, destroyed the adjacent ribs, and showed intense FDG uptake with SUVmax of 12.7. This case indicates that thoracic SMARCA4-deficient undifferentiated tumor should be included in the differential diagnosis of FDG-avid pleural lesions.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference12 articles.

1. Recent updates in thoracic SMARCA4-deficient undifferentiated tumor;Semin Diagn Pathol,2021

2. SMARCA4-deficient thoracic sarcomas: clinicopathologic study of 30 cases with an emphasis on their nosology and differential diagnoses;Am J Surg Pathol,2019

3. SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior;Mod Pathol,2017

4. Molecular, clinicopathological characteristics and surgical results of resectable SMARCA4-deficient thoracic tumors;J Cancer Res Clin Oncol,2023

5. A case of thoracic SMARCA4-deficient undifferentiated tumor successfully treated with combination ipilimumab-nivolumab;Clin Case Rep,2022

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thoracic SMARCA4-Deficient Undifferentiated Tumor Mimicking Malignant Pleural Mesothelioma on FDG PET/CT;Clinical Nuclear Medicine;2024-07-01

2. Thoracic SMARCA4-Deficient Undifferentiated Tumor Mimicking a Pleural Mesothelioma on 18F-FDG PET/CT;Clinical Nuclear Medicine;2024-05-14

3. SMARCA4-Deficient Poorly Differentiated Adenocarcinoma of the Gallbladder;Clinical Nuclear Medicine;2024-04-08

4. Occult SMARCA4-Deficient Undifferentiated Carcinoma Unmasked by 68Ga-FAPI-46 PET/CT;Clinical Nuclear Medicine;2024-03-23